Optomed Oyj

Major Shareholding Notification • Oct 19, 2020

Disclosure 387795

Optomed Oyj - Major shareholder announcements

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc Stock Exchange Release 19 October 2020 at 15.00, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from OP-Rahastoyhtiö Oy (“OP-Rahastoyhtiö”). According to the notification, the total holdings in Optomed shares and votes held by OP -Rahastoyhtiö has increased to 5.08 per cent of all of the registered shares in Optomed on 16 October 2020. The total number of the Company’s registered shares amounts to 14,003,144 shares. Each share entitles to one vote. The total position of OP-Rahastoyhtiö subject to the notification: % of % of shares and voting rights Total of shares and through financial instruments (total both in % voting of B) (A+B) rights (total of A) Resulting 5.08 % - 5.08 % situation on the date on which threshold was crossed or reached Position of - - - previous notification (if applicable) Notified details of the resulting situation on the date on which the threshold was crossed or reached: A: Shares and voting rights Class/type of Number % of shares and voting rights sharesISIN of code shares and voting rights Direct Indirect Direct Indirect (SMA 9:5) (SMA 9:6 (SMA 9:5) (SMA 9:6 ja 9:7) ja 9:7) FI4000410881 711,092 - 5,08 % - SUBTOTAL A 711,092 5.08 % Information in relation to the person subject to the notification obligation as contained in the notification The complete chain of controlled undertakings through which the shares, voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity: Name % of shares % of shares and voting rights Total and voting through financial instruments of rights both OP-Rahastoyhtiö Oy - - - OP-Suomi 2.67 - 2.67 Mikroyhtiöt -sijoitusrahasto OP-Suomi 2.41 2.41 Pienyhtiöt -sijoitusrahasto Further enquiries Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358(0)50 562 4077. Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.